retatrutide peptide injection site Sites for Retatrutide: UK Clinical Trial Guidance – Bolt Pharmacy Where to Inject Retatrutide: A

Tirzepatide, a dual GIP/GLP-1 receptor agonist, has demonstrated a greater reduction in HbA1c (up to 2.4%) than conventional GLP-1 agonists [4]

She rated the instructions a 5 out of 5

The primary concern is lack of additional efficacy clinical studies have not demonstrated meaningful improvements in glycaemic control when DPP-4 inhibitors are added to GLP-1-based therapies

From a clinical perspective, these metabolic considerations suggest that structured nutritional monitoring may accompany long-term GLP-1RA therapy, particularly in individuals with increased susceptibility to lean mass loss or micronutrient insufficiency

These reflect either elevated cardiometabolic risk (prediabetes) or established cardiovascular disease (prior heart attack, prior stroke, symptomatic PAD)